746 related articles for article (PubMed ID: 20476599)
1. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
2. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
3. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
[TBL] [Abstract][Full Text] [Related]
4. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
Maiz N; Plasencia W; Dagklis T; Faros E; Nicolaides K
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):256-60. PubMed ID: 18307193
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus.
Minnella GP; Crupano FM; Syngelaki A; Zidere V; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 May; 55(5):637-644. PubMed ID: 31875326
[TBL] [Abstract][Full Text] [Related]
6. Screening performance of congenital heart defects in first trimester using simple cardiac scan, nuchal translucency, abnormal ductus venosus blood flow and tricuspid regurgitation.
Karadzov Orlic N; Egic A; Damnjanovic-Pazin B; Lukic R; Joksic I; Mikovic Z
Congenit Heart Dis; 2019 Nov; 14(6):1094-1101. PubMed ID: 31573148
[TBL] [Abstract][Full Text] [Related]
7. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
Yang Y; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
[TBL] [Abstract][Full Text] [Related]
8. First-trimester detection of major cardiac defects with the use of ductus venosus blood flow.
Borrell A; Grande M; Bennasar M; Borobio V; Jimenez JM; Stergiotou I; Martinez JM; Cuckle H
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):51-7. PubMed ID: 23152003
[TBL] [Abstract][Full Text] [Related]
9. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
[TBL] [Abstract][Full Text] [Related]
10. [Screening performance of first trimester nuchal translucency, ductus venosus blood flow and tricuspid regurgitation for cardiac defects].
Geipel A; Gembruch U
Z Geburtshilfe Neonatol; 2012 Aug; 216(4):157-61. PubMed ID: 22926815
[TBL] [Abstract][Full Text] [Related]
11. First-trimester measurement of the ductus venosus pulsatility index and the prediction of congenital heart defects.
Timmerman E; Clur SA; Pajkrt E; Bilardo CM
Ultrasound Obstet Gynecol; 2010 Dec; 36(6):668-75. PubMed ID: 20617506
[TBL] [Abstract][Full Text] [Related]
12. The nuchal translucency and the fetal heart: a literature review.
Clur SA; Ottenkamp J; Bilardo CM
Prenat Diagn; 2009 Aug; 29(8):739-48. PubMed ID: 19399754
[TBL] [Abstract][Full Text] [Related]
13. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
Matias A; Huggon I; Areias JC; Montenegro N; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Nov; 14(5):307-10. PubMed ID: 10623988
[TBL] [Abstract][Full Text] [Related]
14. Screening performances of abnormal first-trimester ductus venosus blood flow and increased nuchal translucency thickness in detection of major heart defects.
Karadzov-Orlic N; Egic A; Filimonovic D; Damnjanovic-Pazin B; Milovanovic Z; Lukic R; Mandic V; Joksic I; Vukomanovic V; Kosutic J; Djuricic S; Mikovic Z
Prenat Diagn; 2015 Dec; 35(13):1308-15. PubMed ID: 26408089
[TBL] [Abstract][Full Text] [Related]
15. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects.
Chelemen T; Syngelaki A; Maiz N; Allan L; Nicolaides KH
Fetal Diagn Ther; 2011; 29(2):127-34. PubMed ID: 21160164
[TBL] [Abstract][Full Text] [Related]
16. Is the addition of the ductus venosus useful when screening for aneuploidy and congenital heart disease in fetuses with normal nuchal translucency?
Prats P; Ferrer Q; Comas C; Rodríguez I
Fetal Diagn Ther; 2012; 32(1-2):138-43. PubMed ID: 22585666
[TBL] [Abstract][Full Text] [Related]
17. Cardiac function in trisomy 21 fetuses.
Clur SA; Oude Rengerink K; Ottenkamp J; Bilardo CM
Ultrasound Obstet Gynecol; 2011 Feb; 37(2):163-71. PubMed ID: 20814928
[TBL] [Abstract][Full Text] [Related]
18. Absence of an anatomical origin for altered ductus venosus flow velocity waveforms in first-trimester human fetuses with increased nuchal translucency.
Burger NB; Matias A; Kok E; de Groot CJ; Christoffels VM; Bekker MN; Haak MC
Prenat Diagn; 2016 Jun; 36(6):537-44. PubMed ID: 27060369
[TBL] [Abstract][Full Text] [Related]
19. First-trimester ductus venosus screening for cardiac defects: a meta-analysis.
Papatheodorou SI; Evangelou E; Makrydimas G; Ioannidis JP
BJOG; 2011 Nov; 118(12):1438-45. PubMed ID: 21668765
[TBL] [Abstract][Full Text] [Related]
20. First-trimester ductus venosus velocity ratio as a marker of major cardiac defects.
Wagner P; Eberle K; Sonek J; Berg C; Gembruch U; Hoopmann M; Prodan N; Kagan KO
Ultrasound Obstet Gynecol; 2019 May; 53(5):663-668. PubMed ID: 30125415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
